Last checked at 19 Feb 2021 12:40
IN BRIEF: Scancell Non-Exec Director Diggle Sells 1.3 Million Shares
IN BRIEF: Scancell Non-Exec Director Diggle Sells 1.3 Million Shares
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Scancell Holdings Share News (SCLP)
SCLP Share
Price
SCLP Share
News
SCLP Share
Chat6
SCLP Share
Trades10
SCLP
Live RNS1
SCLP Share
Charts
SCLP Level 2
Console
SCLP Live
Share Price
SCLP Broker
Ratings
SCLP Directors
Deals
SCLP Financial
Diary
SCLP
Fundamentals
SCLP Short
Positions
SCLP
Media
Scancell Holdings Information
Share Price Information for Scancell Holdings (SCLP)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
9.65
Bid:
9.50
Ask:
9.80
Change:
-0.20 (-2.03%)
Spread:
0.30 (3.158%)
Open:
9.75
High:
9.85
Low:
9.65
Prev. Close:
9.85
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.17 Feb 2021 16:22
IN BRIEF: Scancell Non-Exec Director Diggle Sells GBP95,000 In Shares
IN BRIEF: Scancell Non-Exec Director Diggle Sells GBP95,000 In Shares
Read more3 Feb 2021 14:53
Scancell ends clinical development partnership with Cancer Research UK
(Sharecast News) - Novel immunotherapy developer Scancell updated the market on its SCIB2 clinical development partnership with Cancer Research UK on Wednesday, reporting that due to the impact of the Covid-19 pandemic and Cancer Research UK's re-evaluation of its collaboration model, the parties had agreed to end their clinical development partnership.
Read more3 Feb 2021 11:20
CORRECT: AIM WINNERS & LOSERS: Brave Bison Charges Ahead
CORRECT: AIM WINNERS & LOSERS: Brave Bison Charges Ahead
Read more3 Feb 2021 11:11
AIM WINNERS & LOSERS: Brave Bison Charges Ahead On Contract Win
AIM WINNERS & LOSERS: Brave Bison Charges Ahead On Contract Win
Read more3 Feb 2021 09:48
Scancell Assessing SCIB2 Options As Cancer Research UK Pact Ends
Scancell Assessing SCIB2 Options As Cancer Research UK Pact Ends
Read more29 Jan 2021 15:05
IN BRIEF: Scancell Posts Interim Pretax Loss; To Develop Virus Vaccine
IN BRIEF: Scancell Posts Interim Pretax Loss; To Develop Virus Vaccine
Read more21 Dec 2020 19:39
Oxford Technology VCTs In Mixed Quarter Amid Scancell Rise, Ixaris Hit
Oxford Technology VCTs In Mixed Quarter Amid Scancell Rise, Ixaris Hit
Read more18 Dec 2020 10:45
UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura
UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura
Read more18 Dec 2020 10:26
Scancell Shares Rise As It Chooses Vaccine Candidate For Development
Scancell Shares Rise As It Chooses Vaccine Candidate For Development
Read more18 Dec 2020 10:17
Scancell selects Covid-19 vaccine candidate for development and trials
(Sharecast News) - Immunotherapy developer Scancell has selected its Covid-19 vaccine candidate 'SN14' for further development and clinical trials, it announced on Friday.
Read more16 Dec 2020 09:21
DIRECTOR DEALINGS: Scancell Non-Executive Diggle Buys 750,000 Shares
DIRECTOR DEALINGS: Scancell Non-Executive Diggle Buys 750,000 Shares
Read more14 Dec 2020 16:59
UK DIRECTOR DEALINGS SUMMARY: Tracsis CFO Sells GBP480,000 In Shares
UK DIRECTOR DEALINGS SUMMARY: Tracsis CFO Sells GBP480,000 In Shares
Read more25 Nov 2020 16:44
UK DIRECTOR DEALINGS SUMMARY: IG Design Chair Banks GBP1.2 Million
UK DIRECTOR DEALINGS SUMMARY: IG Design Chair Banks GBP1.2 Million
Read more17 Nov 2020 15:40
UK EXECUTIVE CHANGE SUMMARY: Naked Wines, Tissue Regenix Make US Moves
UK EXECUTIVE CHANGE SUMMARY: Naked Wines, Tissue Regenix Make US Moves
Read more